New policy proposal charts the future of early Alzheimer’s treatment
WRAP mPI Sterling Johnson, PhD, is co-author of a forthcoming Policy View in the March issue of The Lancet Neurology. The paper offers recommendations in Alzheimer’s disease treatment and prevention, with important considerations for treatments in people who are cognitively unimpaired but at risk of future symptoms.
February 24, 2026
Dr. Jessica Caldwell explores gender differences in Alzheimer’s disease as new WRAP study leader
Caldwell joined UW–Madison in September 2025 as the multi-principal investigator of the Wisconsin Registry for Alzheimer’s Prevention study
November 18, 2025
UW–Madison Alzheimer’s disease researchers present new findings at 2025 international conference
More than 50 researchers from UW-Madison Alzheimer’s disease research programs joined thousands of global experts at the Alzheimer’s Association International Conference 2025 (AAIC), held July 27-July 31 in Toronto, Canada.
August 7, 2025
WRAP Info Sessions are back
The 2025 WRAP Info Sessions will be held Sept. 30 to Oct. 14 in multiple locations in Wisconsin: Neenah, Milwaukee, Madison, La Crosse
July 30, 2025
Two leading dementia researchers join UW–Madison
UW–Madison’s School of Medicine and Public Health is adding Henrik Zetterberg, a Swedish scientist who studies biomarkers, and Hartmuth Kolb, a German-born chemist and expert in imaging technology, to its faculty.
July 16, 2025
Read all about it: news from our study team in the latest WRAP newsletter
Keeping research participants informed about the study's findings and work is one of the foundational priorities of the WRAP study. To help with that goal, the study team sends a printed newsletter to participants twice each year.
June 12, 2025
Dr. Nathaniel Chin discusses UW–Madison role in Alzheimer’s disease blood tests with regional media outlets
Nathaniel Chin, MD, medical director of the WRAP study, appeared on numerous Wisconsin news outlets to discuss the recent Food and Drug Administration (FDA) approval of a blood test for Alzheimer’s disease. The accuracy of the blood test was validated using data samples from the Wisconsin Alzheimer’s Disease Research Center (ADRC) and the Wisconsin Registry for Alzheimer’s Prevention (WRAP).
June 3, 2025- WRAP news archive
